Ellis Sean
SEC insider (Form 3/4/5 filer). CIK 0001904752. Director at Entera Bio Ltd. (ENTX). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in JERUSALEM.
Companies Ellis Sean has filed insider reports for
- Entera Bio Ltd. (ENTX): Director
Ellis Sean
CIK: 0001904752
Transaction Breakdown
Open Market Buys (P)2 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENTX
Entera Bio Ltd.
Director
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Aug 7, 2026ENTX
Entera Bio Ltd.
AwardDirect20K shares- - Mar 5, 2026ENTX
Entera Bio Ltd.
PurchaseDirect10K shares at avg. $1.23$12K - Feb 9, 2026ENTX
Entera Bio Ltd.
PurchaseDirect18K shares at avg. $1.24$22K - Jan 1, 2026ENTX
Entera Bio Ltd.
AwardDirect25.4K shares- - Jan 15, 2025ENTX
Entera Bio Ltd.
AwardDirect7.1K shares- - Oct 2, 2024ENTX
Entera Bio Ltd.
AwardDirect7.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 7, 2026 | ENTX Entera Bio Ltd. | Award | 20,034 | - | $0 | Direct |
| Mar 5, 2026 | ENTX Entera Bio Ltd. | Purchase | 10,000 | $1.23 | $12,300 | Direct |
| Feb 9, 2026 | ENTX Entera Bio Ltd. | Purchase | 18,000 | $1.24 | $22,320 | Direct |
| Jan 1, 2026 | ENTX Entera Bio Ltd. | Award | 25,371 | - | $0 | Direct |
| Jan 15, 2025 | ENTX Entera Bio Ltd. | Award | 7,100 | - | $0 | Direct |
| Oct 2, 2024 | ENTX Entera Bio Ltd. | Award | 7,466 | - | $0 | Direct |
1-6 of 6 transactions